13F filerCIK 1061768 ↗

Baupost Group

You are looking at Q1 2024. See the latest, Q3 2026 →

Reported value

$3.65B

−20% on the quarter before

Positions

22

6 new, 7 sold out

Top 10

85.6%

of the value

Est. gain

−$52.3M

on stocks held all quarter

Est. return

−1.5%

on those stocks since Q4 2023

Filed

May 14, 2024

On SEC EDGAR ↗

Positions as of Mar 31, 2024, from Baupost Group's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.

Portfolio at a glance

  • New
  • Added
  • Cut
  • Same
  • Options

Each tile is a position, sized by its share, colored by what the fund did with it since Q4 2023. Striped tiles are options.

Liberty Global Ltd20%
Alphabet12%
Willis Towers Watson Plc Ltd12%
Fidelity Natl Information Sv11%
Viasat Inc7.4%
Crh Plc6.4%
Clarivate Plc6.2%
Liberty Media Corp Del3.5%
Liberty Global Ltd3.3%
Outbrain Inc2.8%
Jazz Pharmaceuticals Plc2.7%
Liberty Media Corp Del2.2%
Jacobs Solutions Inc2.1%
Eagle Matls Inc2.0%
Theravance Biopharma Inc1.6%
Wesco Intl Inc1.0%
0.9%
0.6%
0.5%

Largest buys

Since Q4 2023, sized at quarter-end prices.

  1. Outbrain Inc~$102.5MNew, 0.0% → 2.8% of the portfolio+118,000,000 shares
  2. Eagle Matls Inc~$71.2MNew, 0.0% → 2.0% of the portfolio+262,000 shares
  3. Clarivate Plc~$37.9MAdded, 5.2% → 6.2% of the portfolio+5,098,402 shares
  4. Wesco Intl Inc~$35.2MNew, 0.0% → 1.0% of the portfolio+205,724 shares
  5. Gds Hldgs Ltd~$17.3MNew, 0.0% → 0.5% of the portfolio+2,600,000 shares
  6. Fortrea Hldgs Inc~$12.2MNew, 0.0% → 0.3% of the portfolio+303,797 shares
  7. Herbalife Ltd~$5.7MAdded, 0.6% → 0.6% of the portfolio+565,124 shares
  8. SoundHound AI~$5.6MNew, 0.0% → 0.2% of the portfolio+1,130,636 shares
  9. Alphabet~$1.2MAdded, 9.1% → 12.3% of the portfolio+8,114 shares

Largest sells

Since Q4 2023, sized at quarter-end prices.

  1. Liberty Media Corp Del~$312.0MCut, 9.3% → 3.5% of the portfolio−10,500,000 shares
  2. Warner Bros Discovery Inc~$187.9MCut, 6.3% → 0.9% of the portfolio−21,521,164 shares
  3. Liberty Media Corp Del~$163.3MCut, 5.1% → 2.2% of the portfolio−5,500,000 shares
  4. Tower Semiconductor Ltd~$82.7MSold out, 1.8% → 0.0% of the portfolio−2,710,852 shares
  5. Liberty Media Corp Del~$69.4MSold out, 1.5% → 0.0% of the portfolio−1,899,547 shares
  6. Ss&C Technologies Hldgs Inc~$62.9MSold out, 1.4% → 0.0% of the portfolio−1,028,545 shares
  7. Fidelity Natl Information Sv~$58.0MCut, 8.3% → 11.3% of the portfolio−781,750 shares
  8. Crh Plc~$54.9MCut, 5.0% → 6.4% of the portfolio−636,000 shares
  9. Jacobs Solutions Inc~$34.0MCut, 2.1% → 2.1% of the portfolio−221,000 shares
  10. Gray Television Inc~$33.7MSold out, 0.7% → 0.0% of the portfolio−3,760,000 shares

Holdings

As of Mar 31, 2024; changes in shares since Dec 31, 2023.

Positions, sorted by share of the portfolio
HoldingValue
Liberty Global LtdCOM CL C · shares 0% · price −5.4%20.4%$746.4M−$42.3M
AlphabetCAP STK CL C · shares +0.3% · price +8.0%12.3%$450.3M+$33.4M
Willis Towers Watson Plc LtdSHS · shares 0% · price +14.0%11.7%$427.8M+$52.6M
Fidelity Natl Information SvCOM · shares −12% · price +23.5%11.3%$413.8M+$78.7M
Viasat IncCOM · shares −7.1% · price −35.3%7.4%$271.9M−$148.2M
Crh PlcORD · shares −19% · price +24.7%6.4%$233.7M+$46.3M
Clarivate PlcORD SHS · shares +20% · price −19.8%6.2%$227.3M−$46.7M
Liberty Media Corp DelCOM LBTY SRM S C · shares −71% · price +3.2%3.5%$129.3M+$4.0M
Liberty Global LtdCOM CL A · shares 0% · price −4.8%3.3%$121.7M−$6.1M
Outbrain IncNOTE 2.950% 7/2 · shares New2.8%$102.5M—
Jazz Pharmaceuticals PlcSHS USD · shares 0% · price −2.1%2.7%$100.4M−$2.2M
Liberty Media Corp DelCOM LBTY SRM S A · shares −67% · price +3.3%2.2%$79.5M+$2.6M
Jacobs Solutions IncCOM · shares −30% · price +18.4%2.1%$77.9M+$12.1M
Eagle Matls IncCOM · shares New2.0%$71.2M—
Theravance Biopharma IncCOM · shares −11% · price −20.2%1.6%$59.1M−$15.0M
Wesco Intl IncCOM · shares New0.97%$35.2M—
Warner Bros Discovery IncCOM SER A · shares −85% · price −23.3%0.89%$32.4M−$9.8M
Herbalife LtdCOM SHS · shares +34% · price −34.1%0.62%$22.6M−$8.8M
Gds Hldgs LtdSPONSORED ADS · shares New0.47%$17.3M—
Altice Usa IncCL A · shares 0% · price −19.7%0.34%$12.5M−$3.1M
Fortrea Hldgs IncCOMMON STOCK · shares New0.33%$12.2M—
SoundHound AICLASS A COM · shares New0.15%$5.6M—
Total 22 positions100%$3.65B−$52.3M

Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.

What made money

From Q4 2023 to Q1 2024: 16 stocks held throughout, down $52.3M (−1.5%).

  1. Fidelity Natl Information Sv+$78.7M+23%
  2. Willis Towers Watson Plc Ltd+$52.6M+14%
  3. Crh Plc+$46.3M+25%
  4. Alphabet+$33.4M+8%
  5. Jacobs Solutions Inc+$12.1M+18%
  6. Warner Bros Discovery Inc−$9.8M−23%
  7. Theravance Biopharma Inc−$15.0M−20%
  8. Liberty Global Ltd−$42.3M−5%
  9. Clarivate Plc−$46.7M−20%
  10. Viasat Inc−$148.2M−35%

Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out.

Reported value by quarter

Pick a quarter to see what the fund held then.

$20.00B$10.00B$0
Q1 2016Q3 2026
Every quarter's filing
Each quarter's 13F filing, newest first
QuarterReported valueFiling
Q3 2026$5.05B−7%SEC ↗
Q2 2026$5.42B+6%SEC ↗
Q1 2026$5.12B−3%SEC ↗
Q4 2025$5.28B+10%SEC ↗
Q3 2025$4.79B+16%SEC ↗
Q2 2025$4.13B+18%SEC ↗
Q1 2025$3.50B+2%SEC ↗
Q4 2024$3.43B−2%SEC ↗
Q3 2024$3.52B−3%SEC ↗
Q2 2024$3.63B−0%SEC ↗
Q1 2024$3.65B−20%SEC ↗
Q4 2023$4.59B−12%SEC ↗
Q3 2023$5.21B−7%SEC ↗
Q2 2023$5.61B−4%SEC ↗
Q1 2023$5.85B−5%SEC ↗
Q4 2022$6.13B+6%SEC ↗
Q3 2022$5.79B−14%SEC ↗
Q2 2022$6.77B−27%SEC ↗
Q1 2022$9.30B−8%SEC ↗
Q4 2021$10.13B−7%SEC ↗
Q3 2021$10.88B−12%SEC ↗
Q2 2021$12.33B−2%SEC ↗
Q1 2021$12.56B+16%SEC ↗
Q4 2020$10.84B+17%SEC ↗
Q3 2020$9.25B+15%SEC ↗
Q2 2020$8.01B+18%SEC ↗
Q1 2020$6.77B−25%SEC ↗
Q4 2019$9.06B+3%SEC ↗
Q3 2019$8.83B−20%SEC ↗
Q2 2019$11.05B−7%SEC ↗
Q1 2019$11.90B+3%SEC ↗
Q4 2018$11.52B−12%SEC ↗
Q3 2018$13.06B+14%SEC ↗
Q2 2018$11.44B+10%SEC ↗
Q1 2018$10.37B+3%SEC ↗
Q4 2017$10.11B+26%SEC ↗
Q3 2017$8.02B−8%SEC ↗
Q2 2017$8.75B+3%SEC ↗
Q1 2017$8.49B+11%SEC ↗
Q4 2016$7.67B+9%SEC ↗
Q3 2016$7.04B−4%SEC ↗
Q2 2016$7.37B+6%SEC ↗
Q1 2016$6.92BSEC ↗

Subscribe to TheInference for free